查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1824565

2025年全球AI癌症诊断市场报告

AI In Cancer Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年，基于人工智慧的癌症诊断市场将呈指数级增长，到2029年将达到16.5亿美元，复合年增长率为20.0%。预测期内的成长归因于可解释人工智慧的兴起、全球医疗保健支出的成长、与电子健康记录(EHR) 的整合、个人化医疗的普及以及人工智慧演算法的持续进步。预测期内的主要趋势包括成像技术的进步、技术融合、医疗保健公司与科技公司之间的合作、数位病理学的兴起以及组织病理学检测的自动化。

未来五年20.0%的成长率预测较先前的预测略有下降0.1%。这一下降主要源自于美国与其他国家之间关税的影响。预计关税壁垒将阻碍美国市场的发展，因为这将提高来自英国和加拿大的人工智慧组织病理学扫描仪和基因组分析软体的成本，减缓精准肿瘤学的普及，并增加病理学实验室的支出。由于互惠关税以及日益加剧的贸易紧张局势和限制对全球经济和贸易的负面影响，其影响也将更加广泛。

癌症发生率的上升预计将推动人工智慧在癌症诊断市场的成长。癌症是指一组以异常细胞生长为特征的疾病，这些细胞会侵袭并转移到身体的其他部位。人工智慧在癌症治疗中的应用旨在提高效率、准确性和个人化治疗方案，最终改善癌症患者的预后。例如，美国政府机构国家癌症研究所在 2024 年 5 月预测，2024 年美国将诊断出约 200 万例新癌症病例，导致超过 611,000 人死亡。到 2040 年，全球新癌症病例预计将增加到 2,990 万例，癌症相关死亡人数将达到 1,530 万例。因此，癌症发生率的上升正在推动人工智慧在癌症诊断市场的应用。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球人工智慧癌症诊断：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球基于人工智慧的癌症诊断市场：成长率分析
  • 全球基于人工智慧的癌症诊断市场表现：规模与成长，2019-2024
  • 全球基于人工智慧的癌症诊断市场预测：规模与成长，2024-2029 年，2034 年
  • 全球基于人工智慧的癌症诊断：总潜在市场（TAM）

第六章 市场细分

  • 全球基于人工智慧的癌症诊断市场：按组成部分、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 软体解决方案
  • 硬体
  • 服务
  • 全球人工智慧癌症诊断市场（按癌症类型、表现和预测），2019-2024 年、2024-2029 年、2034 年
  • 乳癌
  • 肺癌
  • 脑肿瘤
  • 皮肤癌和子宫颈癌
  • 摄护腺癌和结肠癌
  • 其他类型的癌症
  • 全球基于人工智慧的癌症诊断市场：按应用、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 筛检和诊断
  • 肿瘤识别
  • 监控
  • 全球基于人工智慧的癌症诊断市场：按最终用户、业绩和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 诊断中心
  • 医学研究所
  • 合约研究组织
  • 全球基于人工智慧的癌症诊断市场：按软体解决方案（类型）、效能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 机器学习软体
  • 深度学习软体
  • 影像分析软体
  • 全球基于人工智慧的癌症诊断市场：按硬体（类型）细分、效能和预测，2019-2024 年、2024-2029 年、2034 年
  • 人工智慧成像系统
  • 诊断设备
  • 全球基于人工智慧的癌症诊断市场：按服务类型、绩效和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 人工智慧整合服务
  • 咨询和培训服务
  • 支援和维护服务

第七章 区域和国家分析

  • 全球基于人工智慧的癌症诊断市场：按地区、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 全球基于人工智慧的癌症诊断市场：按国家/地区、表现和预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 基于人工智慧的癌症诊断市场：竞争格局
  • 基于人工智慧的癌症诊断市场：公司简介
    • Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
    • IBM Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Babylon Healthcare Services Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Verily Life Sciences LLC Overview, Products and Services, Strategy and Financial Analysis
    • Tempus Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Guardant Health
  • Lunit Inc.
  • Paige AI Inc.
  • Ada Health GmbH
  • Viz.ai Inc.
  • Butterfly Network Inc.
  • Insilico Medicine
  • BenevolentAI SA SA
  • Enlitic Inc.
  • Ibex Medical Analytics
  • Kheiron Medical Technologies Limited
  • CureMetrix Inc.
  • CancerIQ Inc.
  • MultiplAI Health
  • Freenome Holdings Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029 年人工智慧癌症诊断市场：提供新机会的国家
  • 2029年基于人工智慧的癌症诊断市场：细分领域将带来新机会
  • 2029年基于人工智慧的癌症诊断市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r27273u

AI in cancer diagnostics involves employing artificial intelligence technologies such as machine learning and deep learning to analyze medical images, genetic data, or patient histories for aiding in the early detection, diagnosis, and prognosis of cancer. These systems can detect patterns and anomalies in data that may elude human perception, thereby enhancing diagnostic accuracy and efficiency.

The primary components of AI in cancer diagnostics include software solutions, hardware, and services. Software solutions utilize artificial intelligence (AI) and machine learning (ML) technologies to enhance the accuracy and efficiency of cancer detection, prognosis, and treatment selection. Various types of cancer, including breast cancer, lung cancer, brain tumors, skin cancer, cervical cancer, prostate cancer, colorectal cancer, and others, are addressed. These applications encompass screening and diagnosis, tumor identification, and monitoring, and are utilized by a range of end-users such as hospitals, diagnostic centers, medical research institutes, and contract research organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The AI in cancer diagnostics market research report is one of a series of new reports from The Business Research Company that provides AI in cancer diagnostics market statistics, including AI in cancer diagnostics industry global market size, regional shares, competitors with an AI in cancer diagnostics market share, detailed AI in cancer diagnostics market segments, market trends, and opportunities, and any further data you may need to thrive in the AI in cancer diagnostics industry. This AI in cancer diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ai in cancer diagnostics market size has grown exponentially in recent years. It will grow from $0.66 billion in 2024 to $0.79 billion in 2025 at a compound annual growth rate (CAGR) of 21.0%. The growth in the historic period can be attributed to increasing cancer incidence rates, data explosion in healthcare, supportive regulatory environment, focus on precision medicine, expansion of AI applications beyond imaging.

The ai in cancer diagnostics market size is expected to see exponential growth in the next few years. It will grow to $1.65 billion in 2029 at a compound annual growth rate (CAGR) of 20.0%. The growth in the forecast period can be attributed to emergence of explainable AI, global increase in healthcare it spending, integration with electronic health records (EHR), personalized medicine adoption, continued advances in AI algorithms. Major trends in the forecast period include advancements in imaging technologies, technological convergence, collaborations between healthcare and tech companies, rise of digital pathology, automation in histopathology.

The forecast of 20.0% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. market by increasing the cost of AI-powered histopathology scanners and genomic analysis software sourced from the UK and Canada, thereby slowing precision oncology adoption and elevating pathology lab expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of cancer is expected to drive the growth of artificial intelligence in the cancer diagnostics market. Cancer refers to a group of diseases characterized by abnormal cell growth that can invade or spread to other parts of the body. The integration of AI in cancer care aims to improve efficiency, accuracy, and personalized treatment options, ultimately enhancing outcomes for cancer patients. For example, in May 2024, the National Cancer Institute, a US-based government agency, projected that approximately 2 million new cancer cases would be diagnosed in the U.S. in 2024, with over 611,000 deaths expected. By 2040, global new cancer cases are anticipated to rise to 29.9 million, with cancer-related deaths reaching 15.3 million. As a result, the growing prevalence of cancer is driving the adoption of artificial intelligence in the cancer diagnostics market.

Leading companies in the AI in cancer diagnostics market are experiencing notable growth driven by advancements in AI-powered digital pathology solutions for cancer diagnosis. These solutions utilize AI algorithms to detect cancer and other diagnostic features in various tissue types, offering accurate and timely cancer diagnosis, supporting case prioritization, and ensuring reproducible diagnoses. For instance, in November 2023, Dedalus & Ibex Medical Analytics introduced an integrated End-to-End AI-powered digital pathology solution for cancer diagnosis across Europe. This solution aims to enhance accuracy, provide AI-powered decision support tools, streamline reporting, improve laboratory efficiency, and boost diagnostic confidence.

In December 2023, Lunit, a South Korean AI company, acquired Volpara for $193 million, aiming to establish the combined entity as a leading force in AI-driven cancer diagnostics, particularly in the U.S. market. Volpara's extensive presence in over 2,000 medical sites across the U.S. and its vast database of over 100 million high-quality mammogram images position it as a valuable addition to Lunit's capabilities. Volpara, based in New Zealand, specializes in providing AI-powered software for personalized screening and early detection of breast cancer.

Major companies operating in the AI in cancer diagnostics market report are Microsoft Corporation, IBM Corporation, Babylon Healthcare Services Ltd., Verily Life Sciences LLC, Tempus, Guardant Health, Lunit Inc., Paige AI Inc., Ada Health GmbH, Viz.ai Inc., Butterfly Network Inc., Insilico Medicine, BenevolentAI SA SA, Enlitic Inc., Ibex Medical Analytics, Kheiron Medical Technologies Limited, CureMetrix Inc., CancerIQ Inc., MultiplAI Health, Freenome Holdings Inc., SkinVision, Entopsis, Owkin, Imagen Technologies, Panakeia Technologies, EchoPixel Inc., X-Zell Inc., Cyrcadia Health, Oncora Medical, Xilis

North America was the largest region in the artificial intelligence in cancer diagnostics market in 2024. The regions covered in the AI in cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the AI in cancer diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

AI in the cancer diagnostics market consists of revenues earned by entities by providing services such as early detection and screening, image analysis and interpretation, predictive analytics, and treatment planning. The market value includes the value of related goods sold by the service provider or included within the service offering. The AI in Cancer Diagnostics market also consists of sales of medical imaging devices, pathology analysis systems, genomic sequencing equipment, and patient monitoring devices that are used in providing services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

AI In Cancer Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ai in cancer diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ai in cancer diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ai in cancer diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Component: Software Solutions; Hardware; Services
  • 2) By Cancer Type: Breast Cancer; Lung Cancer; Brain Tumor; Skin Cancer And Cervical Cancer; Prostate And Colorectal Cancer; Other Cancer Types
  • 3) By Application: Screening And Diagnosis; Tumor Identification; Monitoring
  • 4) By End User: Hospitals; Diagnostic Centers; Medical Research Institutes; Contract Research Organizations
  • Subsegments:
  • 1) By Software Solutions: Machine Learning Software; Deep Learning Software; Image Analysis Software
  • 2) By Hardware: AI-Powered Imaging Systems; Diagnostic Devices
  • 3) By Services: AI Integration Services; Consulting And Training Services; Support And Maintenance Services
  • Companies Mentioned: Microsoft Corporation; IBM Corporation; Babylon Healthcare Services Ltd.; Verily Life Sciences LLC; Tempus; Guardant Health; Lunit Inc.; Paige AI Inc.; Ada Health GmbH; Viz.ai Inc.; Butterfly Network Inc.; Insilico Medicine; BenevolentAI SA SA; Enlitic Inc.; Ibex Medical Analytics; Kheiron Medical Technologies Limited; CureMetrix Inc.; CancerIQ Inc.; MultiplAI Health; Freenome Holdings Inc.; SkinVision; Entopsis; Owkin; Imagen Technologies; Panakeia Technologies; EchoPixel Inc.; X-Zell Inc.; Cyrcadia Health; Oncora Medical; Xilis
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. AI In Cancer Diagnostics Market Characteristics

3. AI In Cancer Diagnostics Market Trends And Strategies

4. AI In Cancer Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global AI In Cancer Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global AI In Cancer Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global AI In Cancer Diagnostics Market Growth Rate Analysis
  • 5.4. Global AI In Cancer Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global AI In Cancer Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global AI In Cancer Diagnostics Total Addressable Market (TAM)

6. AI In Cancer Diagnostics Market Segmentation

  • 6.1. Global AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Software Solutions
  • Hardware
  • Services
  • 6.2. Global AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Breast Cancer
  • Lung Cancer
  • Brain Tumor
  • Skin Cancer And Cervical Cancer
  • Prostate And Colorectal Cancer
  • Other Cancer Types
  • 6.3. Global AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Screening And Diagnosis
  • Tumor Identification
  • Monitoring
  • 6.4. Global AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic Centers
  • Medical Research Institutes
  • Contract Research Organizations
  • 6.5. Global AI In Cancer Diagnostics Market, Sub-Segmentation Of Software Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Machine Learning Software
  • Deep Learning Software
  • Image Analysis Software
  • 6.6. Global AI In Cancer Diagnostics Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • AI-Powered Imaging Systems
  • Diagnostic Devices
  • 6.7. Global AI In Cancer Diagnostics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • AI Integration Services
  • Consulting And Training Services
  • Support And Maintenance Services

7. AI In Cancer Diagnostics Market Regional And Country Analysis

  • 7.1. Global AI In Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global AI In Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific AI In Cancer Diagnostics Market

  • 8.1. Asia-Pacific AI In Cancer Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China AI In Cancer Diagnostics Market

  • 9.1. China AI In Cancer Diagnostics Market Overview
  • 9.2. China AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India AI In Cancer Diagnostics Market

  • 10.1. India AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan AI In Cancer Diagnostics Market

  • 11.1. Japan AI In Cancer Diagnostics Market Overview
  • 11.2. Japan AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia AI In Cancer Diagnostics Market

  • 12.1. Australia AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia AI In Cancer Diagnostics Market

  • 13.1. Indonesia AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea AI In Cancer Diagnostics Market

  • 14.1. South Korea AI In Cancer Diagnostics Market Overview
  • 14.2. South Korea AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe AI In Cancer Diagnostics Market

  • 15.1. Western Europe AI In Cancer Diagnostics Market Overview
  • 15.2. Western Europe AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK AI In Cancer Diagnostics Market

  • 16.1. UK AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany AI In Cancer Diagnostics Market

  • 17.1. Germany AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France AI In Cancer Diagnostics Market

  • 18.1. France AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy AI In Cancer Diagnostics Market

  • 19.1. Italy AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain AI In Cancer Diagnostics Market

  • 20.1. Spain AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe AI In Cancer Diagnostics Market

  • 21.1. Eastern Europe AI In Cancer Diagnostics Market Overview
  • 21.2. Eastern Europe AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia AI In Cancer Diagnostics Market

  • 22.1. Russia AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America AI In Cancer Diagnostics Market

  • 23.1. North America AI In Cancer Diagnostics Market Overview
  • 23.2. North America AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA AI In Cancer Diagnostics Market

  • 24.1. USA AI In Cancer Diagnostics Market Overview
  • 24.2. USA AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada AI In Cancer Diagnostics Market

  • 25.1. Canada AI In Cancer Diagnostics Market Overview
  • 25.2. Canada AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America AI In Cancer Diagnostics Market

  • 26.1. South America AI In Cancer Diagnostics Market Overview
  • 26.2. South America AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil AI In Cancer Diagnostics Market

  • 27.1. Brazil AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East AI In Cancer Diagnostics Market

  • 28.1. Middle East AI In Cancer Diagnostics Market Overview
  • 28.2. Middle East AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa AI In Cancer Diagnostics Market

  • 29.1. Africa AI In Cancer Diagnostics Market Overview
  • 29.2. Africa AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. AI In Cancer Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. AI In Cancer Diagnostics Market Competitive Landscape
  • 30.2. AI In Cancer Diagnostics Market Company Profiles
    • 30.2.1. Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. IBM Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Babylon Healthcare Services Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Verily Life Sciences LLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Tempus Overview, Products and Services, Strategy and Financial Analysis

31. AI In Cancer Diagnostics Market Other Major And Innovative Companies

  • 31.1. Guardant Health
  • 31.2. Lunit Inc.
  • 31.3. Paige AI Inc.
  • 31.4. Ada Health GmbH
  • 31.5. Viz.ai Inc.
  • 31.6. Butterfly Network Inc.
  • 31.7. Insilico Medicine
  • 31.8. BenevolentAI SA SA
  • 31.9. Enlitic Inc.
  • 31.10. Ibex Medical Analytics
  • 31.11. Kheiron Medical Technologies Limited
  • 31.12. CureMetrix Inc.
  • 31.13. CancerIQ Inc.
  • 31.14. MultiplAI Health
  • 31.15. Freenome Holdings Inc.

32. Global AI In Cancer Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The AI In Cancer Diagnostics Market

34. Recent Developments In The AI In Cancer Diagnostics Market

35. AI In Cancer Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 AI In Cancer Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 AI In Cancer Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 AI In Cancer Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer